Life recorders’ are being invested in by all the big AI players, with their champions saying the notes and prompts made from ...

On this episode of Primer, we explore the world of biocomputing, where scientists are blurring the lines between the biological and synthetic.

CBCC will initially recruit for the NEO100-01 Glioblastoma (GBM) clinical trial, which is a Phase 2a study evaluating the survival impact and tolerance of intranasal NEO100, an ultra-purified perillyl ...

Gülçin Yildirim, a database administrator, received an invitation for a meeting at an Istanbul chocolate shop with 11 other ...

A growing body of research shows that the adult brain is far more adaptable than we once believed. The concept of ...

We've been bemoaning the lack of progress in the design of iOS, with the iPhone software having looked pretty much the same ...

These are some of the TV shows that are so good, I'd wipe my memory just so I could experience them for the first time all ...

Sean Fitzpatrick, CEO of LexisNexis North America, UK & Ireland, noted that the company is planning to integrate its ...

NeOnc Technologies Holdings, Inc. (to be listed on the NASDAQ Global Market under the symbol: NTHI) , a clinical-stage medical biotechnology company, today announced that it has appointed Dr. Alan ...

Itay&Beyond grows brain tissue from patient urine stem cells to test neurological drugs, training the chips via video games ...

In recent years, many engineers have been trying to develop hardware components that could emulate the functions of various ...